Position in AGEN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$132,242
+$100,970 QoQ
Shares Held
43,217
+361.6% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 103 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in AGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,774,320 across 417 Biotechnology names. AGEN ranks #276 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in AGEN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $132,242 | 43,217 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $31,272 | 9,363 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $31,977 | 10,184 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $51,284 | 13,321 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $45,055 | 9,859 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $35,342 | 23,406 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $63,772 | 23,275 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $197,190 | 35,984 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $769,845 | 45,961 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $562,686 | 970,150 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $839,338 | 1,011,252 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $2,594,595 | 2,296,103 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,741,042 | 2,338,152 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $3,025,226 | 1,990,279 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $3,049,677 | 1,270,699 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,737,061 | 1,335,153 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,707,070 | 1,395,400 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,901,190 | 1,179,347 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,373,853 | 1,047,781 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $5,861,582 | 1,116,492 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $5,902,220 | 1,075,086 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $2,853,019 | 1,048,904 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $3,717,045 | 1,168,883 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $4,807,080 | 1,201,771 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $4,829,458 | 1,228,871 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $2,763,346 | 1,127,896 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||